Department of Pharmaceutical Science and Research, Marshall University School of Pharmacy, Huntington, WV, USA.
Tulane School of Medicine, Center for Translational Research in Infection and Inflammation, New Orleans, LA, USA.
Eur J Immunol. 2018 Jan;48(1):39-49. doi: 10.1002/eji.201646721. Epub 2017 Aug 31.
The intestine is a critical site of immune cell development that not only controls intestinal immunity but extra-intestinal immunity as well. Recent findings have highlighted important roles for gut microbiota in shaping lung inflammation. Here, we discuss interactions between the microbiota and immune system including T cells, protective effects of microbiota on lung infections, the role of diet in shaping the composition of gut microbiota and susceptibility to asthma, epidemiologic evidence implicating antibiotic use and microbiota in asthma and clinical trials investigating probiotics as potential treatments for atopy and asthma. The systemic effects of gut microbiota are partially attributed to their generating metabolites including short chain fatty acids, which can suppress lung inflammation through the activation of G protein-coupled receptors. Thus, studying the interactions between microbiota and immune cells can lead to the identification of therapeutic targets for chronic lower respiratory diseases.
肠道是免疫细胞发育的关键部位,不仅控制肠道免疫,还控制肠道外免疫。最近的研究结果强调了肠道微生物群在塑造肺部炎症方面的重要作用。在这里,我们讨论了微生物群与免疫系统(包括 T 细胞)之间的相互作用,微生物群对肺部感染的保护作用,饮食在塑造肠道微生物群组成和易感性方面的作用哮喘、抗生素使用和微生物群在哮喘中的流行病学证据以及临床试验调查益生菌作为治疗特应性和哮喘的潜在疗法。肠道微生物群的全身效应部分归因于它们产生的代谢物,包括短链脂肪酸,通过激活 G 蛋白偶联受体抑制肺部炎症。因此,研究微生物群与免疫细胞之间的相互作用可以为慢性下呼吸道疾病的治疗靶点的确定提供线索。